Sign In
Buy APDN
$5.62
+0 (+0%)
At Close: Jan 05, 2026
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs May 13.) * AstraZeneca plc (NYSE: AZN) * AtriCure Inc. (NASD
Shares of Applied DNA Sciences jump 66% on regulatory authorization of its COVID-19 test
11:12am, Thursday, 14'th May 2020
Shares of Applied DNA Sciences Inc. [: apdn] soared 66.2% in premarket trading on Thursday after the company announced emergency use authorization from the...
Shares of Applied DNA Sciences jump 66% on regulatory authorization of its COVID-19 test
11:12am, Thursday, 14'th May 2020
Shares of Applied DNA Sciences Inc. [: apdn] soared 66.2% in premarket trading on Thursday after the company announced emergency use authorization from the Food and Drug Administration for its COVID-1
Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
09:00am, Thursday, 14'th May 2020
Applied DNA Sciences Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company," "our") announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the
Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
12:00am, Thursday, 14'th May 2020
Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company,” “our”) announced today that the U.S. Food and Drug Administration (FDA) has
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET
12:00pm, Thursday, 07'th May 2020
Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2020 second quarter ended March 31, 2020 after market close on Thursday, May 14, 2020. I
Stock Charts To Watch: CARS, DQ, LPSN, OSTK, SE, SPCE
12:00am, Thursday, 07'th May 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Natural Gas Futures, Dynavax Technologies Corporation, Horizon Pharma PLC. Read Harry Boxer's latest article on Investing.com
Applied DNA Receives Approximately $5.3 Million in Net Proceeds from Warrant Exercise
12:00pm, Wednesday, 06'th May 2020
Applied DNA Sciences Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company") a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables diagnostics, pre-clinical nucleic acid-based
Applied DNA Applies to U.S. FDA for Emergency Use Authorization for COVID-19 Diagnostic Kit
01:32pm, Tuesday, 05'th May 2020
Applied DNA Sciences Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company," "our") today announced that it applied prior to the end of April for U.S. Food and Drug Administration (FDA) Emergency Use Aut
Important Technical Indicators to watch- Applied DNA Sciences, Inc. (NASDAQ:APDN)’s E-P-S strolling at -7.33, - Stocks Equity
10:16pm, Monday, 04'th May 2020
On Monday, Applied DNA Sciences, Inc. (NASDAQ:APDN)’s highest estimates of price target are $8.00 and low forecast is $8.00 based on the opinion of 1 [...]
Applied DNA Sciences Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company" or "we/our") today announced with its COVID-19 vaccine development partner Takis Biotech ("Takis") that the first injections of
Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company” or “we/our”) today announced with its COVID-19 vaccine development partner Ta
Stocks To Watch: Jobs Report, Virtual Conferences And Blue Chips On Tap
01:09pm, Saturday, 02'nd May 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) today announced that the Emerging Technology Team (ETT) of the U.S. Food and Drug
